Inside China’s biotech boom
🤖 AI-generated content — The title and summary were produced automatically by artificial intelligence, without human editorial review.
Drugs designed in China now make up roughly half of the global development pipeline. STAT’s Jason Mast traveled to Shanghai to examine the industry’s rapid growth and the competition causing concern in the United States.
Continue in the app — vote & join in ➔Source: STAT News · via ahirlevel.hu